ORCHPHARMA.BO(ORCHPHARMA.BO)
ORCHPHARMA.BO
BSE • Last print unknown ago
$946.50—Stale · unknown old
No analyst ratings available
No analyst price targets available for ORCHPHARMA.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $14.43B | $20.04B |
| Low | $14.43B | $20.04B |
| High | $14.43B | $20.04B |
| EBITDA Avg | $1.85B | $4.38B |
| Low | $1.85B | $4.38B |
| High | $1.85B | $4.38B |
| EBIT Avg | $902M | $2.93B |
| Low | $902M | $2.93B |
| High | $902M | $2.93B |
| Net Income Avg | $583M | $2.15B |
| Low | $583M | $2.15B |
| High | $583M | $2.15B |
| EPS Avg | $11.50 | $42.40 |
| Low | $11.50 | $42.40 |
| High | $11.50 | $42.40 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $2.32B |
| Low | $2.32B |
| High | $2.32B |
| EBITDA Avg | — |
| Low | — |
| High | — |
| EBIT Avg | — |
| Low | — |
| High | — |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |